Methods for Increasing Genetic Testing Uptake in Michigan (MiGHT)
Breast Cancer, Colorectal Cancer, Ovarian Cancer
About this trial
This is an interventional health services research trial for Breast Cancer focused on measuring Genetic testing, Genetic susceptibility to malignant neoplasm
Eligibility Criteria
Inclusion Criteria:
- Able to speak and read English
- Access to the internet
- Completed the Family Health History Tool (FHHT) through the Michigan Oncology Quality Consortium (MOQC).
Meeting clinical criteria for genetic evaluation due to any of the below:
Breast cancer either:
- i. Diagnosed under 50
- ii. PREMM risk model score ≥ 2.5%
- iii. Personal or family history of triple negative breast cancer
- iv. Ashkenazi Jewish ancestry
- v. Male proband
- vi. 1st or 2nd degree relative with ovarian cancer, pancreatic cancer, breast cancer diagnosed under 50, or male breast cancer
Endometrial cancer either:
- i. Diagnosed under 50
- ii. PREMM risk model score ≥ 2.5%
Prostate cancer either:
- i. Diagnosed under 50
- ii. PREMM risk model score ≥ 2.5%
- iii. Ashkenazi Jewish ancestry
- iv. 1st or 2nd degree relative with ovarian cancer, pancreatic cancer, breast cancer diagnosed under 50, or male breast cancer
Colorectal cancer either:
- i. Diagnosed under 50
- ii. PREMM risk model score ≥ 2.5%
- Ovarian cancer
- Pancreatic cancer
Exclusion Criteria:
- Prior clinical germline genetic testing for cancer or already have an upcoming appointment scheduled with a genetics provider
Sites / Locations
- University of Michigan Rogel Cancer CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Experimental
Experimental
Arm 1 - Usual care (UC)
Arm 2 - Virtual genetics navigator
Arm 3 - Motivational interviewing (MI)
Participants are provided with a link to the Michigan Department of Health and Human Services (MDHHS) informational website and are instructed to follow up with their oncology provider about genetic testing.
Participants receive access to an online genetics tool, the virtual genetics navigator, to help learn why and how to seek out genetic testing for hereditary cancer syndromes.
Participants receive up to 2 phone calls from trained genetics health coaches who provide information about genetic testing and use motivational interviewing to encourage participants to seek out clinical genetic testing.